Press Releases | 4 April 2022

bioLytical Laboratories Inc. reçoit l’autorisation de Santé Canada pour le test à domicile de dépistage antigénique de la COVID-19 iStatis

bioLytical Laboratories Inc. a annoncé aujourd’hui le lancement d’un deuxième test sur sa nouvelle plateforme iStatis, après avoir reçu l’autorisation de Santé Canada pour l’entrée immédiate sur le marché canadien de son test à domicile de dépistage antigénique de la COVID-19 iStatis

Read More »

News | 31 August 2021

bioLytical Laboratories Named as One of BC’s Fastest-Growing Companies for the Fifth Year

bioLytical Laboratories Inc. has been named one of the fastest-growing companies in British Columbia for 2021, our fifth straight year on the list.

Read More »

News | 12 July 2021

bioLytical receives CE Mark for the World’s First One Minute Hepatitis C (HCV) Antibody Test

bioLytical Laboratories Inc. announced today that its INSTI® HCV Antibody Test has received approval for immediate market entry into the European Union.

Read More »


  • bioLytical® Laboratories develops and manufactures a rapid HIV diagnostic product, the INSTI® Kit. It is a unique, simple-to-use diagnostic kit used in the diagnosis of HIV infection. At 60 seconds for a reading, INSTI® Kit is the fastest HIV diagnostic assay in the world today. The INSTI® HIV-1/HIV-2 Antibody Test is a rapid in vitro qualitative test for the detection of antibodies to Human Immunodeficiency Virus Type 1 or Type 2 in human whole blood, fingerstick blood, or plasma.

  • You are currently viewing content for the EUROPE region. Accept